Loftus, Australia

Carsten Schmitz-Peiffer

This inventor holds 1 USPTO granted patent. Top assignee: Garvan Institute of Medical Research. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Carsten Schmitz-Peiffer. Retrieved from https://idiyas.com/inventor/carsten-schmitz-peiffer

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Carsten Schmitz-Peiffer: Innovator in Medical Research

Introduction

Carsten Schmitz-Peiffer is a notable inventor based in Loftus, Australia. He has made significant contributions to the field of medical research, particularly in the area of insulin modulation. His work is characterized by a focus on developing innovative assays that can lead to advancements in diabetes treatment.

Latest Patents

Carsten Schmitz-Peiffer holds a patent for a novel invention that provides cell-based and animal-based assays for determining antagonists of PKCε. This invention is crucial for modulating insulin clearance and secretion. The patent also includes the development of novel animals and cells suitable for use in these assays. He has 1 patent to his name.

Career Highlights

Carsten is affiliated with the Garvan Institute of Medical Research, where he conducts his research. His work at this prestigious institution has allowed him to explore various aspects of medical science, particularly in relation to insulin and its effects on the body.

Collaborations

One of his notable collaborators is Trevor John Biden, with whom he has worked on various projects aimed at enhancing the understanding of insulin modulation.

Conclusion

Carsten Schmitz-Peiffer's contributions to medical research through his innovative patents and collaborations highlight his commitment to advancing healthcare solutions. His work continues to pave the way for future discoveries in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…